Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin

被引:4
作者
Becker, A. [1 ]
Stoffels-Weindorf, M. [1 ]
Schimming, T. [1 ]
Dissemond, J. [1 ]
机构
[1] Univ Klinikum Essen, Klin & Poliklin Dermatol Veneral & Allergol, D-45122 Essen, Germany
关键词
chronic wound; leg ulcers; livedoid vasculopathy; atrophie blanche; heparin; ATROPHIE-BLANCHE;
D O I
10.1055/s-0033-1343293
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
History and admission findings: A 50-year-old women had suffered from recurrent and extremely painful ulcerations of both legs and the back of her feet for about 3 weeks. The clinical examination showed multiple hemorrhagic and bizarre configured ulcerations with a surrounding livid-erythematous discoloration, hyperpigmentation and extensive atrophie blanche. Investigations: Neither instrument-based nor serological tests revealed specific pathological findings. Histological results from the border area of the ulceration confirmed the diagnosis of livedoid vasculopathy. Treatment and course: A systemic treatment with low-molecular- weight heparin was initiated, resulting in a rapid pain reduction and complete healing of the ulcerations after some weeks of therapy. Conclusion: This case report demonstrates that unusual entities like livedoid vasculopathy should be considered as rare causes for recurrent leg ulcers because different underlying etiologies need different specific treatment strategies. Until now treatment for patients with livedoid vasculopathy has not been standardized but anticoagulative therapy with low-molecular-weight heparin is considered to be one treatment of first choice.
引用
收藏
页码:1458 / 1462
页数:5
相关论文
共 15 条
[1]   Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy [J].
Agirbasli, Mehmet ;
Eren, Mesut ;
Eren, Fatih ;
Murphy, Sheila B. ;
Serdar, Zehra A. ;
Seckin, Dilek ;
Zara, Tuba ;
Mat, M. Cem ;
Demirkesen, Cuyan ;
Vaughan, Douglas E. .
JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 32 (01) :59-63
[2]   Livedoid vasculopathy: an intringuing cutaneous disease [J].
Criado, Paulo Ricardo ;
Rivitti, Evandro Ararigboia ;
Sotto, Mirian Nacagami ;
Sakai Valente, Neusa Yuriko ;
Aoki, Valeria ;
de Carvalho, Jozelio Freire ;
Vasconcellos, Cidia .
ANAIS BRASILEIROS DE DERMATOLOGIA, 2011, 86 (05) :961-977
[3]   Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs - a prospective study [J].
Di Giacomo, T. B. ;
Hussein, T. P. ;
Souza, D. G. ;
Criado, P. R. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 (11) :1340-1346
[4]  
Dissemond J, 2012, ULCUS CRURIS GRUNDLA
[5]   Update of management of connective tissue diseases: livedoid vasculopathy [J].
Gonzalez-Santiago, Tania M. ;
Davis, Mark D. P. .
DERMATOLOGIC THERAPY, 2012, 25 (02) :183-194
[6]  
Gorge T., 2011, HAUTARZT, V62, P627
[7]   Livedoid vasculopathy - further evidence for procoagulant pathogenesis [J].
Hairston, Bethany R. ;
Davis, Mark D. P. ;
Pittelkow, Mark R. ;
Ahmed, Iftikhar .
ARCHIVES OF DERMATOLOGY, 2006, 142 (11) :1413-1418
[8]  
Huptas L, 2011, HAUTARZT, V62, P280, DOI 10.1007/s00105-011-2141-x
[9]   Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy [J].
Kerk, N. ;
Drabik, A. ;
Luger, T. A. ;
Schneider, S. W. ;
Goerge, T. .
BRITISH JOURNAL OF DERMATOLOGY, 2013, 168 (04) :898-899
[10]   TISSUE PLASMINOGEN-ACTIVATOR FOR TREATMENT OF LIVEDOID VASCULITIS [J].
KLEIN, KL ;
PITTELKOW, MR .
MAYO CLINIC PROCEEDINGS, 1992, 67 (10) :923-933